Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David McGuinness

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
BMC Bioinformatics|August 20, 2021
Searchlight: automated bulk RNA-seq exploration and visualisation using dynamically generated R scriptsJohn J Cole, Bekir A Faydaci, David McGuinness, et al.
Psychiatric Services (Washington, D.C.)|July 4, 2017
Service Users' Experiences of Involuntary Hospital Admission Under the Mental Health Act 2001 in the Republic of IrelandRebecca Murphy, David McGuinness, Emma Bainbridge, et al.
Psychiatry Research|July 13, 2015
Caregivers' perceptions of coercion in psychiatric hospital admissionVeronica Ranieri, Kevin Madigan, Eric Roche, et al.
International Journal of Mental Health Nursing|October 28, 2016
Qualitative exploration of stakeholders' perspectives of involuntary admission under the Mental Health Act 2001 in IrelandSiobhán Smyth, Dympna Casey, Adeline Cooney, et al.
Heart (British Cardiac Society)|March 9, 2026
Proteomic insights into troponin elevation following COVID-19 infectionAnna Kamdar, Daniel Tze Yee Ang, Kenneth Mangion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2020
Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO TrialTalia Golan, Hedy L Kindler, Joon Oh Park, et al.
European Urology Oncology|October 9, 2024
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel TrialNoel W Clarke, Andrew J Armstrong, Mototsugu Oya, et al.
European Urology Oncology|November 18, 2025
Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel StudyAndrew J Armstrong, Fred Saad, Mototsugu Oya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2022
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic CancerHedy L Kindler, Pascal Hammel, Michele Reni, et al.
The New England Journal of Medicine|June 4, 2019
Maintenance Olaparib for Germline <i>BRCA</i>-Mutated Metastatic Pancreatic CancerTalia Golan, Pascal Hammel, Michele Reni, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMC Bioinformatics|August 20, 2021
Searchlight: automated bulk RNA-seq exploration and visualisation using dynamically generated R scriptsJohn J Cole, Bekir A Faydaci, David McGuinness, et al.
Psychiatric Services (Washington, D.C.)|July 4, 2017
Service Users' Experiences of Involuntary Hospital Admission Under the Mental Health Act 2001 in the Republic of IrelandRebecca Murphy, David McGuinness, Emma Bainbridge, et al.
Psychiatry Research|July 13, 2015
Caregivers' perceptions of coercion in psychiatric hospital admissionVeronica Ranieri, Kevin Madigan, Eric Roche, et al.
International Journal of Mental Health Nursing|October 28, 2016
Qualitative exploration of stakeholders' perspectives of involuntary admission under the Mental Health Act 2001 in IrelandSiobhán Smyth, Dympna Casey, Adeline Cooney, et al.
Heart (British Cardiac Society)|March 9, 2026
Proteomic insights into troponin elevation following COVID-19 infectionAnna Kamdar, Daniel Tze Yee Ang, Kenneth Mangion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2020
Geographic and Ethnic Heterogeneity of Germline <i>BRCA1</i> or <i>BRCA2</i> Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO TrialTalia Golan, Hedy L Kindler, Joon Oh Park, et al.
European Urology Oncology|October 9, 2024
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel TrialNoel W Clarke, Andrew J Armstrong, Mototsugu Oya, et al.
European Urology Oncology|November 18, 2025
Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel StudyAndrew J Armstrong, Fred Saad, Mototsugu Oya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2022
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic CancerHedy L Kindler, Pascal Hammel, Michele Reni, et al.
The New England Journal of Medicine|June 4, 2019
Maintenance Olaparib for Germline <i>BRCA</i>-Mutated Metastatic Pancreatic CancerTalia Golan, Pascal Hammel, Michele Reni, et al.
Pageof 3